Navigation Links
Cellceutix CEO, Leo Ehrlich, Conducts Interview with "Biotech Stock Trader"; Dr. Paul Ginsberg, (Renowned Patent Attorney) Joins Cellceutix Advisory Board
Date:4/18/2011

>

Commenting on joining the Cellceutix Advisory Board, Dr. Ginsburg stated, "I have been working closely with Cellceutix and Dr. Menon for some time now and based on my past experience in the field, I see great potential in the Company.  I am both pleased and excited to join the exceptional Cellceutix team and look forward to what the future may hold with not only Kevetrin™, but KM-391 for autism and other drugs in the pipeline which I have gotten to know quite well."

About Dr. Ginsberg

Dr. Ginsburg received his Ph.D. in Chemistry from the City University of New York and his law degree from Columbia University where he was a Harlan Fiske Stone Scholar.  He was elected to Phi Beta Kappa at the City College of New York and to the scientific research honor society Sigma Xi at CUNY. 

Dr. Ginsburg has spent most of his career as corporate counsel representing large and small pharmaceutical, biotechnology, chemical and consumer products companies.  His last position was at Pfizer Inc., where he served as Head of the New York Patent Department which dealt with several blockbuster products, including Viagra and Chantix.  He represented Pfizer on the intellectual property committees of the National Association of Manufacturers, the Chemical Manufacturers Association and the Biotechnology Industry Organization. Dr. Ginsburg has lectured widely on pharmaceutical and biotechnology patent prosecution and licensing at the Practicing Law Institute and Columbia Law School . Prior to his twenty year career at Pfizer, Dr. Ginsburg was a senior attorney at Schering-Plough. He was subsequently recruited by Merck and then by the highly respected IP law firm, Fish & Neave.

Dr. Ginsburg is perhaps most well-known as the author of the patent covering Schering-Plough's hugely successful product Claritin. He also authored important patents covering Schering-Plough's highly successful alpha-interferon product.

D
'/>"/>

SOURCE Cellceutix Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cellceutix Poster Presentation on its p53 Cancer Breakthrough Attracts Wide Interest at 102nd AACR Meeting
2. Cellceutix Reports Production of Its Anti-Cancer Drug Kevetrin™ Has Begun
3. Cellceutix Reports Confidential Disclosure Agreement Signed With Major Pharmaceutical Company
4. Cellceutix Discovers Drug Activates Guardian Angel p53 in Fight Against Leukemia
5. Cellceutix Cancer Drug Kevetrin™ Shows No Genotoxicity in Study
6. Sonic Innovations Conducts National Training Events for Government Clinicians
7. Impliant Conducts the First Two Implantations of Its New TOPS VersaLink Spinal System
8. Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
9. Maine Natural Health Company Conducts Dental Clinical Trial
10. OXIS International Executives Interviewed on StockGoodies.com Radio
11. Cardiogenesis Executive Chairman Paul J. McCormick Updates Commercial and Regulatory Progress in Interview With Wall Street Reporter, Available Online
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... Today, UBM China, a wholly owned subsidiary ... Tianyi Exhibition Co., Ltd. to jointly run the Health ... held concurrently with CWMEE 2016. This ... following MEDTEC China and DENTECH China, and fills its ... It,s also another concrete cooperative project in ...
(Date:6/30/2015)...  July 4 th is this weekend, a time ... and people behind it. To help honor our current nation,s ... USA Medical Card, a leading provider of free ... empower independence for our disabled military veterans, police, firemen, and ... their prescriptions. "Due to USA ...
(Date:6/30/2015)... 30, 2015  Marken, the leading clinical trial logistics ... industry, has been granted permission by the government to ... drug product in Korea.  This precedent-setting shipment has allowed ... to continue receiving their clinical trial drugs during the ... The emergency was caused by recent partial closures of ...
Breaking Medicine Technology:UBM Joins Chengdu Tianyi to Hold CWMEE 2016 2UBM Joins Chengdu Tianyi to Hold CWMEE 2016 3Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2Marken Delivers Direct To Patients During MERS Outbreak 2Marken Delivers Direct To Patients During MERS Outbreak 3
... , an industry-leading vendor of ambulatory healthcare software ... fastest-growing private companies in America. ... http://www.newscom.com/cgi-bin/prnh/20100817/INC5000LOGO ) The listing was published ... an exclusive compilation of the nation,s fastest-growing private ...
... 26 Wound Management Technologies, Inc. (OTC Bulletin Board: ... Wound Care Innovations, LLC has further expanded its rapidly ... the addition of Central Medical Systems to its already ... CMSI is the ideal type of distributor; they have ...
Cached Medicine Technology:Pulse Makes the 2010 Inc. 5000 List of the Fastest-Growing Private Companies in America 2Wound Management Technologies Expands Distribution Foot Print in Florida with the Addition of Central Medical Systems 2Wound Management Technologies Expands Distribution Foot Print in Florida with the Addition of Central Medical Systems 3
(Date:6/30/2015)... ... June 30, 2015 , ... Micro ... company provides high quality record management services for patient records. Medical imaging includes ... required by physicians and clinics. , With the increase in the acceptance ...
(Date:6/30/2015)... Minn. (PRWEB) , ... June 30, 2015 , ... ... mobile-based nurse call and communications software, Notify™, for the senior care sector. As ... forefront of helping senior housing facilities to become more efficient and offer residents ...
(Date:6/30/2015)... ... June 30, 2015 , ... Harbor Village Detox is a drug ... Florida on June 12th. Holly Vasquez-Cortella was recently quoted as an expert in ... to reporting on trending addiction news and treatment innovations. The article highlights Florida governor ...
(Date:6/30/2015)... ... 30, 2015 , ... Nuretix Research, creators of the top ... (KO Zone), a state-of-the-art training facility owned by leading MMA, boxing, ... The partnership will provide KO Zone clients and athletes with Liporidex Fitness Formulas ...
(Date:6/30/2015)... ... , ... Due to today’s housing market, many people cannot afford to “down size” as they ... adjustments as to how to carry laundry or groceries from one level of their home ... or first floor of the home, and the bedrooms are located on another floor. ...
Breaking Medicine News(10 mins):Health News:Micro Com Systems Ltd Now Specializes in Medical Imaging 2Health News:Eldermark Leap-Frogs other Nurse Call and Communication Systems with Notify 2Health News:Eldermark Leap-Frogs other Nurse Call and Communication Systems with Notify 3Health News:Harbor Village Detox’s Clinical Director Is Quoted as an Addiction Expert by The Fix 2Health News:Harbor Village Detox’s Clinical Director Is Quoted as an Addiction Expert by The Fix 3Health News:Top Sports Nutrition Brand, Liporidex, Announces Partnership With Leading Boxing, CrossFit and MMA Gym, Knockout Zone of Miami 2Health News:Top Sports Nutrition Brand, Liporidex, Announces Partnership With Leading Boxing, CrossFit and MMA Gym, Knockout Zone of Miami 3Health News:Butler Mobility Products announce a Solution to Carry Items from One Floor to the Next with a Dumbwaiter 2
... 20 Progen Pharmaceuticals Limited (ASX: PGL; Nasdaq: ... its epigenetic technology successfully inhibits tumor growth.The results ... at the 100th Annual American Association for Cancer ... in ,switching on, important anti-cancer genes - a ...
... April 20 A new alliance between the ... leading manufacturer of unattended massage beds is focused ... a new and affordable service to customers.(Photo: ... Enterprises manufactures the HydroMassage, a massage system that ...
... the University of Southern California have identified a new ... surrounding blood vessels without the negative side effects typically ... 2.5-dimethyl-celecoxib (DMC) appears to have a strong anti-tumor effect ... supply necessary for tumor growth, according to data presented ...
... Fluorescent Channels to Enable Greater Data Ranges and Multiplexing ... Series Launched to Enable Imaging, Co-Registration and Data Fusion ... April 20 VisEn Medical Inc., a ... research through medicine, announced that users of its FMT ...
... added everolimus (Afinitor(R), Novartis) to the NCCN Guidelines for ... renal cell carcinoma whose disease has progressed after treatment ... of the March 30, 2009 FDA approval of everolimus ... that the therapy significantly extended progression-free survival in a ...
... Schwabe North America , has announced the ... Way sales teams. The integration marks an exciting ... Inc. by German-based Dr. Willmar Schwabe Pharmaceuticals, a leading ... years.The combined Specialty Retail Field Sales Team will service ...
Cached Medicine News:Health News:Progen Technology Switches on Cancer Fighting Genes and Inhibits Tumor Growth 2Health News:Progen Technology Switches on Cancer Fighting Genes and Inhibits Tumor Growth 3Health News:Progen Technology Switches on Cancer Fighting Genes and Inhibits Tumor Growth 4Health News:ETS Tan Now Exclusive Distributor of HydroMassage in U.S. 2Health News:USC researchers develop new drug to target tumor cells and blood vessels 2Health News:VisEn Medical Launches Expanded FMT 2500(TM) Imaging Platforms at AACR Meeting 2Health News:VisEn Medical Launches Expanded FMT 2500(TM) Imaging Platforms at AACR Meeting 3Health News:NCCN Updates Kidney Cancer Guidelines to Incorporate FDA Approval of Everolimus 2Health News:NCCN Updates Kidney Cancer Guidelines to Incorporate FDA Approval of Everolimus 3Health News:Schwabe North America Integrates Enzymatic Therapy and Nature's Way Sales Teams 2
For the quantitative determination of Glycohemoglobin in blood....
The BioCheck Ferritin ELISA is intended for the quantitative determination of ferritin in human serum. This assay is to be used in the diagnosis of diseases affecting iron metabolism....
Rapid turn-around time, results in less than 4 hours...
... Bio-Rad isotopic anemia assays ... minimal ,pipetting steps for ... about the processes ,involved ... the benefit to your ...
Medicine Products: